A literature survey on follow-up definitions on the use of infliximab in Crohn's disease.

Ther Adv Gastroenterol · 2025 · PMC12374118 · PMID 40860934

Europe PMC DOI

hedged sentence

0.2520

closest p · 5.0× alpha

0.2520

boldest claim

The sentences

did not reach statistical significancep = 0.252not close (p > 0.1)

In contrast, they had a shorter mean duration for long-term follow-up than their counterparts, but such a difference did not reach statistical significance (35.74 ± 25.21 vs 43.32 ± 35.92 months, p = 0.252).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.